<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02699645</url>
  </required_header>
  <id_info>
    <org_study_id>TRIDENT-1103886</org_study_id>
    <nct_id>NCT02699645</nct_id>
  </id_info>
  <brief_title>Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial</brief_title>
  <acronym>TRIDENT</acronym>
  <official_title>Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The George Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of New South Wales</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The George Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      An investigator initiated and conducted, multicentre, international, double-blinded,
      placebo-controlled, parallel-group, randomised controlled trial, to determine the effects of
      a fixed low-dose combination blood pressure lowering pill (&quot;Triple Pill&quot;) on top of standard
      of care on blood pressure control, and on time to first occurrence of recurrent stroke, in
      patients with a history of acute intracerebral haemorrhage (TRIDENT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute intracerebral haemorrhage (ICH) is the most serious and least treatable form of stroke,
      accounting for at least 10% of the 20 million new strokes that occur globally each year.
      Survivors of ICH are at high risk of recurrent ICH and other serious cardiovascular events.

      While there is strong evidence that this risk can be reduced by lowering the blood pressure
      (BP) of patients after ICH, many patients with ICH do not receive BP-lowering treatment
      long-term unless BP levels are particularly high, and many do not receive BP combination
      therapy.

      The aim of this study is to assess the safety and efficacy of a combination of fixed low-dose
      generic BP lowering agents, as a &quot;Triple Pill&quot; strategy on top of standard of care for the
      prevention of recurrent stroke in patients with a history of ICH and high normal or low grade
      hypertension. The study is a large-scale, international, double-blind, placebo-controlled,
      randomised controlled trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 28, 2017</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrent Stroke</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Time to first occurrence of recurrent stroke, whether ischaemic or haemorrhagic.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrent ICH</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Time to first occurrence of recurrent ICH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischaemic Stroke</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Time to first occurrence of ischaemic stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal or disabling stroke</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Time to first occurrence of fatal or disabling stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Major adverse cardiovascular events - CV death, non-fatal MI or non-fatal stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Physical function as assessed by smRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SBP</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Change in SBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HRQoL according to the EQ-5D-3L</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Health-related quality of life according to the European Quality of Life 5-Dimensional Assessment, 3-Level version</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Impairment</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Overall defined by standard cut-points on the Montreal Cognitive Assessment (MoCA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Impairment Supplement</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Overall defined by standard cut-points with Brief Memory and Executive Test (BMET)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>Average of 3 years</time_frame>
    <description>Self-reported measures, Pill counts</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Acute Intracerebral Haemorrhage (ICH)</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Triple Pill (active treatment)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>received via blinded study capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg</intervention_name>
    <description>1 capsule taken orally once daily for average of 36 months</description>
    <arm_group_label>Triple Pill (active treatment)</arm_group_label>
    <other_name>Triple Pill</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>1 capsule taken orally once daily for average of 36 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (â‰¥18 years) with a history of up to 12 months after symptom onset of primary
             ICH that is confirmed by imaging (copy of the brain imaging report to be uploaded to
             the database, labelled with participant identification (ID) and with personal
             identifiers removed)

          -  Clinically stable, as judged by investigator

          -  Average of two resting SBP levels measured 5 minutes apart in the range 130-160mmHg
             recorded in a seated position (National Heart Foundation of Australia Guidelines).
             (Patients with higher SBP can be included if considered by attending clinician that
             management is consistent with local standards of clinical practice)

          -  Geographical proximity to the recruiting hospital and/or follow-up medical clinic site
             to allow ready access for in-person clinic visits during follow-up

          -  No clear contraindication to any of the study treatments

          -  Provision of written informed consent

        Exclusion Criteria:

          -  Taking an ACE-I that cannot be switched to any of the following alternatives:

               -  telmisartan 20 or 40mg, amlodipine 2.5 or 5mg, indapamide 1.25mg, or

               -  an equivalent class (ARB, CCB or thiazide [TZ]-like diuretic), or

               -  a BB

          -  Contraindication to any of the study medications, in the context of currently
             prescribed BP-lowering medication

          -  Unable to complete the study procedures and/or follow-up

          -  Females of child-bearing age and capability, who are pregnant or breast-feeding, or
             those of child-bearing age and capability who are not using adequate birth control

          -  Significant hyperkalaemia and/or hyponatremia, in the opinion of the responsible
             physician

          -  Estimated glomerular filtration rate (eGFR) &lt;30mL/min/1.73m2

          -  Severe hepatic impairment (alanine aminotransferase [ALT] or aspartate
             aminotransferase [AST] &gt;3x the upper limit of normal [ULN])

          -  Any other condition that in the opinion of the responsible physician investigator
             renders the patient unsuitable for the study (e.g. severe disability [i.e. simplified
             modified Rankin Scale (smRS) of 4-5] or significant memory or behavioural disorder)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Craig Anderson</last_name>
    <role>Principal Investigator</role>
    <affiliation>The George Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Grace Balicki</last_name>
    <phone>+61 2 8052 4811</phone>
    <email>gbalicki@georgeinstitute.org.au</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ruth Freed</last_name>
    <phone>+61 2 8052 4522</phone>
    <email>rfreed@georgeinstitute.org.au</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Calvary Public Hospital</name>
      <address>
        <city>Bruce</city>
        <state>Australian Capital Territory</state>
        <zip>2617</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>2170</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Miller</last_name>
      <email>Megan.Miller1@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Dennis Cordato</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Port Macquarie Base Hospital</name>
      <address>
        <city>Port Macquarie</city>
        <state>New South Wales</state>
        <zip>2444</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Parrey</last_name>
      <email>kim.parrey@ncahs.health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Matt Kinchington</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>Saint Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Mitchell</last_name>
      <email>Nicola.Mitchell@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Tim Ang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacci Watson</last_name>
      <email>jacqueline.watson@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Andy Evans</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sunshine Coast University Hospital</name>
      <address>
        <city>Birtinya</city>
        <state>Queensland</state>
        <zip>4575</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Simmons</last_name>
    </contact>
    <investigator>
      <last_name>Rohan Grimley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Queensland Centre for Clinical Research</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Bendall</last_name>
      <email>Carol.Bendall@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Darshan Shah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Jackson</last_name>
      <email>David.Jackson@mh.org.au</email>
    </contact>
    <investigator>
      <last_name>Nawaf Yassi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>Western Australia</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole O'Loughlin</last_name>
      <email>nicole.oloughlin@health.wa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Darshan Ghia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital das ClÃ­nicas de Botucatu</name>
      <address>
        <city>Botucatu</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernanda Winckler</last_name>
      <email>fernanda_winckler@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Rodrigo Bazan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Celso Ramos</name>
      <address>
        <city>FlorianÃ³polis</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gabriel Martins Rodrigues</last_name>
      <email>gabrielrodrigues90@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica NeurolÃ³gica e Neurocirurgica de Joinville</name>
      <address>
        <city>Joinville</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Paula de Oliveira Pires</last_name>
      <email>centrodepesquisaavc@neurologica.com.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital das ClÃ­nicas de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natacha Fleck</last_name>
      <email>pesquisaneurovascular@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Shiela Cristina Ouriques Martins</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Moinhos de Vento</name>
      <address>
        <city>Porto Alegre</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Hospital das ClÃ­nicas de RibeirÃ£o Preto</name>
      <address>
        <city>RibeirÃ£o Preto</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henrique Afonso S. Pereira</last_name>
      <email>haspereira@hcrp.usp.br</email>
    </contact>
    <investigator>
      <last_name>Octavio Marques Pontes Neto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Base SÃ£o JosÃ© do Rio Preto</name>
      <address>
        <city>Rio PrÃªto</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thiago Souza</last_name>
      <email>thiagosouza.cip@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de Salvador (HBA)</name>
      <address>
        <city>Salvador</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalia Oliveira</last_name>
      <email>assistente.pesquisa@hospitaldabahia.com.br</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universidade Federal de SÃ£o Paulo</name>
      <address>
        <city>SÃ£o Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ilana Izidoro da Silva</last_name>
      <email>ilana.silva@fapunifesp.edu.br</email>
    </contact>
    <investigator>
      <last_name>Gisele Sampiao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Coutinho</last_name>
      <email>j.coutinho@amc.nl</email>
    </contact>
    <investigator>
      <last_name>Yvo Roos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <zip>6815 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Simons</last_name>
      <email>MCMsimons@rijnstate.nl</email>
    </contact>
    <investigator>
      <last_name>Jeannette Hofmeijer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zuyderland Medical Centre</name>
      <address>
        <city>Heerlen</city>
        <zip>6419 PC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiny Simons-Sporken</last_name>
      <email>t.sporken@zuyderland.nl</email>
    </contact>
    <investigator>
      <last_name>Tobien Schreuder</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inger de Ridder</last_name>
      <email>i.de.ridder@mumc.nl</email>
    </contact>
    <investigator>
      <last_name>Julie Staals</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Radboud University Medical Center</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525 GC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Floris Schreuder</last_name>
      <email>floris.schreuder@radboudumc.nl</email>
    </contact>
    <investigator>
      <last_name>Karin Klijn</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Centre, Utrecht</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University College Hospital Ibadan</name>
      <address>
        <city>Ibadan</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uvere Ezinne</last_name>
      <email>ezinneuvere13@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Rufus Akinyemi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Ilorin</name>
      <address>
        <city>Ilorin</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunday Adeniyi</last_name>
      <email>sundayadeniyi767@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kolawole W. Wahab</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jos University Teaching Hospital</name>
      <address>
        <city>Jos</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joy Abraham</last_name>
      <email>joyabraham500@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Dr Godwin Osaigbovo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lagos University Teaching Hospital, Lagos</name>
      <address>
        <city>Lagos</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Osigwe P. Agabi</last_name>
      <email>osigweagabi@yahoo.co.uk</email>
    </contact>
    <investigator>
      <last_name>Prof. Njideka Okubadejo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ahmadu Bello University Teaching Hospital</name>
      <address>
        <city>Zaria</city>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wisdom Oguike</last_name>
      <email>wissword@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dr Reginald Obiako</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Isabella Tan</last_name>
      <email>nicole_isabella_tan@nuhs.edu.sg</email>
    </contact>
    <investigator>
      <last_name>Dr. Vincent Nga</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Colombo North Teaching Hospital</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Udaya Ranawake</last_name>
    </contact>
    <investigator>
      <last_name>Udaya Ranawake</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kalubowila (Colombo South) Teaching Hospital</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arjuna Fernando</last_name>
    </contact>
    <investigator>
      <last_name>Arjuna Fernando</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Hospital of Sri Lanka</name>
      <address>
        <city>Colombo</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bimsara Senanayake</last_name>
    </contact>
    <investigator>
      <last_name>Bimsara Senanayake</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karapitiya Teaching Hospital</name>
      <address>
        <city>Galle</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charika Rajinee</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jaffna Teaching Hospital</name>
      <address>
        <city>Jaffna</city>
        <zip>40000</zip>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Priyanth</last_name>
      <email>johnpriyanth@remediumone.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kandy Teaching Hospital</name>
      <address>
        <city>Kandy</city>
        <zip>20000</zip>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Shafras</last_name>
    </contact>
    <investigator>
      <last_name>Indunil Wijeweera, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Teaching Hospital Kurunegala</name>
      <address>
        <city>Kurunegala</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janaka Peiris</last_name>
    </contact>
    <investigator>
      <last_name>Janaka Peiris</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sri Jayewardenepura General Hospital</name>
      <address>
        <city>Nugegoda</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harsha Gunasekara</last_name>
    </contact>
    <investigator>
      <last_name>Harsha Gunasekara</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peradeniya Teaching Hospital</name>
      <address>
        <city>Peradeniya</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadie Ratnayake</last_name>
    </contact>
    <investigator>
      <last_name>Nadie Ratnayake</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ragama Teaching Hospital</name>
      <address>
        <city>Ragama</city>
        <zip>11010</zip>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonali Liyanagamage</last_name>
    </contact>
    <investigator>
      <last_name>Sharshana Wijegunasinghe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marianne Kormann</last_name>
      <email>marianne.kormann@insel.ch</email>
    </contact>
    <investigator>
      <last_name>Urs Fischer, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Zurich</name>
      <address>
        <city>ZÃ¼rich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Chiayi Chang Gung Memorial Hospital</name>
      <address>
        <city>Chiayi City</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pei-Jung Chung</last_name>
      <email>peggy6315@yahoo.com.tw</email>
    </contact>
    <investigator>
      <last_name>Jiann-Der Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Chang Gung Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>833</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei-Chi Lin</last_name>
      <email>sophia666@adm.cgmh.org.tw</email>
    </contact>
    <investigator>
      <last_name>Chia-Wei Liou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Keelung Chang Gung Memorial Hospital</name>
      <address>
        <city>Keelung</city>
        <zip>204</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Linkou Chang Gung Memorial Hospital</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pei-Yu Chuang</last_name>
      <email>uyap123@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Tsong Hai-Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Suffolk Hospital</name>
      <address>
        <city>Bury Saint Edmunds</city>
        <zip>IP33 2QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Countess of Chester</name>
      <address>
        <city>Chester</city>
        <zip>CH2 1UL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Royal Devon &amp; Exeter Hospital</name>
      <address>
        <city>Exeter</city>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth University Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Halifax Royal Infirmary Calderdale Hospital</name>
      <address>
        <city>Halifax</city>
        <zip>HX3 0PW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Victoria Hospital</name>
      <address>
        <city>Kirkcaldy</city>
        <zip>KY2 5AH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Nottingham City Hospital</name>
      <address>
        <city>Nottingham</city>
        <zip>NG5 1PB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Salford Royal Hospital</name>
      <address>
        <city>Salford</city>
        <zip>M6 8HD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Royal Hallamshire Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S10 2JF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Royal Stoke University Hospital</name>
      <address>
        <city>Stoke-on-Trent</city>
        <zip>T4 6QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Netherlands</country>
    <country>Nigeria</country>
    <country>Singapore</country>
    <country>Sri Lanka</country>
    <country>Switzerland</country>
    <country>Taiwan</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2016</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood Pressure (BP)</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amlodipine</mesh_term>
    <mesh_term>Telmisartan</mesh_term>
    <mesh_term>Indapamide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>2 years after publication of main results</ipd_time_frame>
    <ipd_access_criteria>Bone fide researchers submit protocol to the Research Office of The George Institute for Global Health</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

